Grantham, Mayo, Van Otterloo & Co (GMO)
MCHX icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Marchex MCHX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MCHX Stock Details MCHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-69,800
Closed -$137K – 901
2020
Q4 		$137K Sell
69,800
-92,700
-57% -$188K ﹤0.01% 790
2020
Q3 		$345K Sell
162,500
-31,100
-16% -$54.8K ﹤0.01% 676
2020
Q2 		$306K Hold
193,600
– – ﹤0.01% 674
2020
Q1 		$281K Buy
193,600
+7,500
+4% +$21.6K ﹤0.01% 668
2019
Q4 		$703K Sell
186,100
-1,900
-1% -$6.83K ﹤0.01% 558
2019
Q3 		$590K Buy
+188,000
New +$724K ﹤0.01% 612

Other funds holding MCHX

EC
Edenbrook Capital Mt. Kisco, New York $496M AUM 53.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 35.16% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MCHX Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Marchex (MCHX) in Q1 2021, closing a stake of 69,800 shares — an estimated $137K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MCHX in Q3 2019 and held it in 6 quarters. The position peaked at $703K in Q4 2019. 42 funds tracked by Wall St. Rank hold MCHX as of Q1 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Marchex position as of Q1 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 69,800 Marchex shares in Q1 2021, an estimated $137K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Marchex in Q3 2019 and held it in 6 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Marchex position peaked at $703K in Q4 2019.
  • 42 funds tracked by Wall St. Rank held Marchex as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.